CALDERONE, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 16.764
EU - Europa 7.414
AS - Asia 3.993
AF - Africa 283
SA - Sud America 154
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 6
Totale 28.643
Nazione #
US - Stati Uniti d'America 16.329
IT - Italia 3.033
CN - Cina 2.148
SE - Svezia 1.287
SG - Singapore 782
DE - Germania 780
BG - Bulgaria 714
CA - Canada 426
TR - Turchia 385
VN - Vietnam 377
GB - Regno Unito 328
UA - Ucraina 229
FI - Finlandia 227
CI - Costa d'Avorio 184
AT - Austria 177
RU - Federazione Russa 175
FR - Francia 139
BR - Brasile 126
HK - Hong Kong 114
IN - India 78
PL - Polonia 77
CH - Svizzera 74
SN - Senegal 54
BE - Belgio 46
NL - Olanda 30
AU - Australia 24
KR - Corea 22
NG - Nigeria 21
GR - Grecia 19
IR - Iran 12
PK - Pakistan 12
CL - Cile 11
HU - Ungheria 11
JP - Giappone 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
ES - Italia 8
BJ - Benin 7
IE - Irlanda 7
LT - Lituania 7
MX - Messico 6
SK - Slovacchia (Repubblica Slovacca) 6
AR - Argentina 5
EU - Europa 5
HR - Croazia 5
LB - Libano 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
ZA - Sudafrica 5
DK - Danimarca 4
IQ - Iraq 4
VE - Venezuela 4
BD - Bangladesh 3
DZ - Algeria 3
IL - Israele 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
ET - Etiopia 1
ID - Indonesia 1
IS - Islanda 1
JO - Giordania 1
LI - Liechtenstein 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
TH - Thailandia 1
UG - Uganda 1
UY - Uruguay 1
Totale 28.643
Città #
Woodbridge 2.130
Ann Arbor 1.651
Fairfield 1.557
Houston 1.363
Chandler 1.240
Santa Clara 1.151
Ashburn 944
Serra 725
Sofia 714
Milan 684
Shanghai 663
Seattle 637
Wilmington 572
Cambridge 530
Beijing 458
New York 430
Boardman 408
Singapore 397
Ottawa 389
Princeton 313
Jacksonville 298
Lawrence 285
Izmir 263
Medford 235
Nanjing 203
Dong Ket 186
Abidjan 184
Vienna 170
Des Moines 167
Frankfurt am Main 125
London 116
Pisa 110
Chicago 108
Dearborn 107
Istanbul 106
Hong Kong 103
Florence 89
San Diego 89
Nanchang 84
Rome 80
Boulder 77
Warsaw 71
Redwood City 67
Bern 62
Dakar 54
Los Angeles 54
Marseille 54
Ogden 51
Jüchen 50
Washington 47
Brussels 44
Shenyang 43
Kunming 42
Grafing 41
Hebei 37
Changsha 36
Fuzhou 36
Lucca 36
Falls Church 33
Norwalk 32
Dallas 31
Pune 31
Tianjin 31
Bremen 29
Livorno 29
Jiaxing 27
Auburn Hills 26
Nürnberg 26
Guangzhou 25
Hangzhou 25
Quanzhou 24
Munich 22
Toronto 22
Lagos 21
Lancaster 19
Naples 19
Vicopisano 19
Hefei 18
Helsinki 16
Jinan 16
San Francisco 16
Orange 15
Napoli 13
Wuhan 13
Perugia 12
São Paulo 12
Amsterdam 11
Carrara 10
Chengdu 10
Nuremberg 10
Redmond 10
Detroit 9
Shenzhen 9
Brno 8
Hyderabad 8
Indiana 8
Islamabad 8
Phoenix 8
Scafati 8
Tashkent 8
Totale 21.713
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 283
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 229
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 227
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 203
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 194
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 193
Antioxidant, cardiomyocyte anti-ageing properties and phytochemical profile of Citrus bergamia juices 191
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 188
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 188
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 182
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 179
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 178
An update on hybrid drugs in cardiovascular drug research 176
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 174
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 174
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 172
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 171
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 170
Antioxidant and Antisenescence Effects of Bergamot Juice 170
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 168
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 168
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 163
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 161
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 161
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 161
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 158
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 156
Memantine prodrug as a new agent for alzheimer’s disease 153
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 152
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 150
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 150
An alternative method to evaluate the nature of an antagonist and its potency. A theoretical approach 149
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 149
Synthesis of 1,8 - naphthyridine derivatives: potential antihypertensive agents. Part VII 148
A modified aortic multiple-ring preparation for functional studies 147
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 145
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 144
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 143
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 143
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 142
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 142
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 142
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 142
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 142
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 141
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 139
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 139
Synthesis of 1,8-naphthyridine derivatives: potential antihypertensive agents. Part VIII 138
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 137
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 136
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method 134
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 134
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 134
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 134
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 134
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 133
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 132
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 132
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 131
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 130
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 129
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 129
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 128
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 127
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 125
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 124
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 124
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 123
Intrinsic activity and EC50: the simplest tools for the evaluation of the dissociation constant of a partial agonist 122
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 122
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 122
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 122
Vasodilator activity of crude methanolic extract of Gentiana Kokiana Perr Et Song (Gentianaceae) 120
New amido derivatives as potential BKCa potassium channel activators. XI 120
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 119
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 119
Evaluation of the NO-releasing properties of NO-donor linkers 118
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 118
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 117
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 116
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 116
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 115
VASORELAXANT EFFECTS OF THE CHLOROFORMIC CRUDE EXTRACT OF BUPLEURUM FRUTICOSUM L. (UMBELLIFERAE) ROOTS ON RAT THORACIC AORTA 114
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 114
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 114
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 113
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 113
Prediction of hERG Potassium Channel Affinity by the CODESSA Approach 112
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 112
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 112
Editorial for the special issue on "Drugs targeting potassium channels" 111
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 111
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 111
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 111
Synthesis and b-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]-pyridine: potential antihypertensive agents. Part IX 111
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 111
Pharmacological action of aqueous crude extracts of Artemisia verlotorum Lamotte (Compositae) 110
QT PROLONGATION IN ANAESTHETIZED GUINEA-PIGS: AN EXPERIMENTAL APPROACH FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG CANDIDATES 110
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 109
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 109
Totale 14.262
Categoria #
all - tutte 86.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.029 0 0 0 0 0 0 526 343 435 284 335 106
2020/20212.422 176 122 127 109 232 196 130 222 318 202 150 438
2021/20223.287 63 220 98 159 537 536 107 172 130 108 252 905
2022/20234.211 523 540 277 346 465 575 41 272 808 24 212 128
2023/20243.300 333 405 373 189 467 624 147 95 59 88 125 395
2024/20253.790 95 411 126 559 850 1.123 626 0 0 0 0 0
Totale 29.488